Patents
Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
08/2008
08/21/2008US20080199957 therapeutic or diagnostic agent is covalently coupled to the transport agent, which is poly(2-ethylacrylic acid), poly(2-propylacrylic acid), poly(2-butylacrylic acid); drug delivery of proteins, DNA, nucleotides through endosomal membrane
08/21/2008US20080199400 Otologic nanotechnology
08/20/2008CN100411632C Method for extended storage of blood and blood components
08/13/2008EP1537867B1 Method of photodynamic diagnosis for vascular diseases
08/12/2008CA2217551C Photoactivated hypericin and the use thereof
08/07/2008WO2008074804A3 Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application
08/07/2008WO2008026915A3 A pharmaceutical composition for the treatment of a fungal skin disorder and a method for the preparation thereof
08/07/2008US20080187488 Phage antibodies to radiation-inducible neoantigens
08/06/2008EP1952812A1 Drug for treating thalessemia, falciform anemia and all other forms of anemia treatable therewith
08/06/2008EP1951303A2 Therapy with cd4 binding peptides and radiation
08/06/2008EP1744789B1 X-ray and/or uv activatable particles, their preparation and their therapeutic or diagnostic uses
08/06/2008EP1077686B1 Externally triggered microcapsules
08/06/2008CN101237883A Photosensitizers and MRI enhancers
08/06/2008CN100408026C Ceramic based nanoparticles for entrapping therapeutic agents for photodynamic therapy and method of using same
08/05/2008CA2217494C Novel compositions of lipids and stabilizing materials
07/2008
07/31/2008WO2007103132A3 Method and apparatus for acne treatment using low intensity light therapy
07/31/2008US20080181853 nanostructure capsules comprising shells enclosing gas filled hollow cores, rupturable upon exposure to ultrasonic frequencies, to release the gases; consisting an inner layer of polymers and an outer layer of cross-linked amphiphilic materials; echographic imaging of the reticuloendothelial system
07/30/2008EP1603918B1 Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof
07/30/2008EP1494752B1 Method of treating biological materials with translating electrical fields and electrode polarity reversal
07/30/2008CN101232915A Production of means for improving the state of systems and materials
07/29/2008CA2254070C Method for treating viral infections
07/29/2008CA2110490C Drug delivery systems comprising gas-filled liposomes at least 90% devoid of liquid in their interior
07/24/2008US20080176953 Administration of a neuroprotectant( brimonidine, clonidine and para-aminoclonidine) for the treatment of ocular neovascularization (CNV) and macular degeneration; Vision defects; photodynamic therapy; mixture of neuroprotective factor and neovascularization inhibitor
07/23/2008EP1945193A1 Transdermal delivery system for treating infertility
07/23/2008EP1945159A2 Magnetic nanoscale particle compositions, and therapeutic methods related thereto
07/23/2008EP1740144A4 Phototherapy systems and methods
07/23/2008EP1503770A4 Method for extended storage of blood and blood components
07/23/2008EP1469733A4 Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells
07/23/2008CN101227925A Superparamagnetism nanometer particle capable of injecting for thermotherapy and uses forming thermotherapy implanting agent
07/23/2008CN101227890A Method and system for in vivo drug delivery
07/22/2008US7402392 In vivo panning for ligands to radiation-induced molecules
07/22/2008US7402299 Intracorporeal medicaments for photodynamic treatment of disease
07/22/2008CA2283566C Method of measuring physiological function
07/17/2008WO2008084241A2 Use of aminolevulinic acid and derivatives thereof
07/17/2008WO2008083461A1 Plant compositions enriched in dehydrosoyasaponin i (d-i) and methods of producing such compositions
07/17/2008CA2784250A1 Use of aminolevulinic acid and derivatives thereof
07/17/2008CA2675334A1 Reducing side effects associated with ala-based photodynamic therapy
07/17/2008CA2674787A1 Plant compositions enriched in dehydrosoyasaponin i (d-i) and methods of producing such compositions
07/16/2008CN100402105C Apparatus and method for microporation of biological membranes using thin film tissue interface devices
07/10/2008US20080166361 Monoclonal antibody conjugate for targeting 10-boron to tumor cells; boron neutron capture therapy
07/09/2008EP1941905A1 APO-2 Ligand-anti-her-2 antibody synergism
07/09/2008EP1940513A1 A nanoparticle suitable for delivery of a biomolecule into or out of a membrane enclosed cell or cell organelle
07/09/2008EP1940300A2 Method for treating subcutaneous tissues
07/09/2008CA2573484A1 Plant compositions enriched in dehydrosoyasaponin i (d-i) and methods of producing such compositions
07/08/2008CA2188029C Porphocyanine and cnc-expanded porphyrins
07/03/2008US20080161369 Open label, single arm, two stage, multicenter study; patients who have not responded to taxane/platinum therapy or have relapsed within six months
07/03/2008US20080160026 Apo-2 ligand-anti-her-2 antibody synergism
07/02/2008CN101209268A Fluid sound energy Chinese medicine ultra-minuteness processing technique
07/02/2008CN100398153C Combined pharmaceutical application of antiangiogenic drugs and photosensitizers
07/01/2008US7395112 Method and apparatus for treating tumors using low strength electric fields
06/2008
06/26/2008WO2008076333A2 Polymer-drug conjugates with tether groups for controlled drug delivery
06/26/2008WO2008041514A9 Radiation sensitizer or anti-cancer chemotherapy sensitizer
06/26/2008WO2008027445A3 Combination with bis(thiohydrazide amides) for treating cancer
06/26/2008WO2008007290A3 Core-shell nanoparticles for thearapy and imaging purposes
06/26/2008US20080153865 Water soluble paclitaxel derivatives
06/26/2008US20080152689 Devices containing dna encoding neurotrophic agents and related compositions and methods
06/26/2008CA2672810A1 Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application
06/25/2008EP1934138A2 Amphiphilic nanotubes and micelles comprising same for use in the delivery of biologically active agents
06/25/2008EP1933941A2 Treatment systems for delivery of sensitizer solutions
06/25/2008EP1933875A2 Conjugates of photosensitisers and antibodies
06/25/2008EP1811994B1 Novel derivatives of porphyrin, particularly chlorins and bacteriochlorins, and uses thereof in photodynamic therapy
06/25/2008CN101208086A Indoloquinone tumor radiation sensitization
06/24/2008US7390787 Comprising 8 to 25 amino acids and containing the formula: RXZXXZXB wherein Z is proline or valine; X is a hydrophobic residue; and B is a basic amino acid.
06/24/2008US7390668 Halogenated xanthan compound
06/24/2008US7390510 Water soluble complex of hypericin and a polyvinylpyrrolidone; diagnosing and treating tumors
06/19/2008WO2008073856A2 Delivery of nanoparticles and/or agents to cells
06/19/2008WO2008073851A2 Remotely triggered release from heatable surfaces
06/19/2008WO2007019845A8 Method for encapsulating therapeutic substances in cells
06/19/2008US20080147131 Method for muscle delivery of drugs, nucleic acids and other compounds
06/19/2008US20080146784 Moncolonal antibody for use in diagnosis and treatment of cell proliferative disorders; immunotherapy; tissue engineering
06/19/2008US20080146598 Combinatorial drug therapy using polymer-drug conjugates
06/19/2008CA2671850A1 Delivery of nanoparticles and/or agents to cells
06/19/2008CA2671806A1 Remotely triggered release from heatable surfaces
06/18/2008EP1064027B1 Apo-2 ligand-anti-her-2 antibody synergism
06/18/2008CN101200469A Separation of regioisomers of metal phthalocyanines
06/18/2008CN101199846A Heavy ion irradiance method of modifying butt olaquindox, benzo furzazan N-oxide and acetyl flumequine
06/12/2008US20080140138 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
06/12/2008US20080139786 Exposing azo, azide and sulfenate agents to visible or infrared light; use in medical procedures to cause necrosis or apoptosis of tissue
06/11/2008CN101198611A Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them, and their use
06/10/2008US7384977 polymer conjugated drug with polylactams; antitumor, anticancer agents for prostate cancer, breast cancer, ovarian cancer, colon cancer, leukemia, and lung cancer; rheumatic diseases; autoimmune diseases
06/05/2008US20080132963 Method and apparatus for treating tumors using low strength electric fields
06/05/2008US20080132541 immunomodulatory compound is administered in combination with a therapy conventionally used to treat, prevent or manage cancer; potent inhibition of TNF- alpha but also marked inhibition of LPS
06/04/2008WO2008068923A1 Nucleic acid-degrading agent and method for degradation of nucleic acid
06/04/2008EP1926497A2 Use of a photosensitizing agent in the treatment or prevention of an inflammation-associated disorder in the gastrointestinal tract of a mammal
06/04/2008EP1126782B1 Method for improved imaging and photodynamic therapy
06/03/2008US7381404 Treatment for dry macular degeneration
06/03/2008CA2536069C Use of green porphyrins in ocular diagnosis and therapy
06/03/2008CA2298820C The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
05/2008
05/28/2008EP1660475B1 Pyrimidylpyrrole derivatives active as kinase inhibitors
05/28/2008EP1377251B1 A cell therapy method for the treatment of tumors
05/28/2008CN201066605Y Biological information processing instrument
05/28/2008CN101189030A Method for terminal sterilization of transdermal delivery devices
05/22/2008WO2008059419A1 Radiation sensitizers for ionizing electromagnetic radiation therapy and imaging
05/22/2008WO2008018783B1 Porphyrin activation by different spectrum electromagnetical waves-new malignant tumour treatment possibilities
05/21/2008CN101181328A Method for producing ginseng fruit and ginseng flower stalk with high content of ginsenoside
05/20/2008US7375215 Compounds for PDT
05/20/2008US7374778 Enhanced transport using membrane disruptive agents
05/15/2008US20080114285 Energy-activated targeted cancer therapy
05/14/2008EP1920784A1 Radiation sensitizers in ionizing radiation therapy and imaging
05/14/2008EP1919507A2 Nanoparticles comprising antibacterial ligands
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 95